Company Filing History:
3 out of 14 
3 out of 1,290 
1 out of 8 Years Active: 2020-2021
Title: Maria Falkenberg-Gustafsson: Innovator in Cancer Treatment
Introduction
Maria Falkenberg-Gustafsson is a prominent inventor based in Mölndal, Sweden. She has made significant contributions to the field of cancer treatment through her innovative research and development of novel compounds. With a total of three patents to her name, her work focuses on advancing medical science and improving therapeutic options for patients.
Latest Patents
One of her latest patents is titled "Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer." This invention provides novel coumarin derivatives that act as specific mitochondrial RNA polymerase inhibitors, offering new avenues for cancer treatment. Another significant patent is "Method to detect activity of a polymerase," which relates to methods for detecting nucleotide polymerase activity. This invention includes techniques for identifying compounds that modulate nucleotide polymerase activity, utilizing proximity-dependent energy transfer methods, such as Förster resonance energy transfer. Additionally, the invention provides kits that contain components necessary for carrying out these detection methods.
Career Highlights
Throughout her career, Maria has worked with esteemed organizations, including Lead Discovery Center GmbH and Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Her work in these institutions has allowed her to contribute to groundbreaking research and development in the field of biotechnology.
Collaborations
Maria has collaborated with notable colleagues, including Tim Bergbrede and Nils-Göran Larsson. These partnerships have further enhanced her research capabilities and have led to significant advancements in her field.
Conclusion
Maria Falkenberg-Gustafsson is a trailblazer in the realm of cancer treatment innovations. Her patents and collaborative efforts reflect her commitment to advancing medical science and improving patient outcomes. Her contributions are invaluable to the ongoing fight against cancer.